Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
220.36
-0.14 (-0.06%)
At close: Dec 5, 2025, 4:00 PM EST
219.64
-0.72 (-0.33%)
After-hours: Dec 5, 2025, 7:16 PM EST
Cidara Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -184.74 | -169.83 | -22.93 | -33.58 | -42.47 | -72.11 | |
| Depreciation & Amortization | 0.16 | 0.23 | 0.12 | 0.14 | 0.19 | 1.05 | |
| Other Amortization | - | 0.18 | 0.08 | - | 0 | 0.01 | |
| Loss (Gain) From Sale of Investments | -0.17 | - | - | - | - | - | |
| Stock-Based Compensation | 9.53 | 3.91 | 3.06 | 3.53 | 4.01 | 4.09 | |
| Other Operating Activities | -8.03 | 1.1 | 1.16 | 0.98 | -1.41 | 0.02 | |
| Change in Accounts Receivable | -0.16 | 14.28 | -10.41 | -0.48 | 5.82 | -11.17 | |
| Change in Inventory | - | 6.1 | -6.1 | - | - | - | |
| Change in Accounts Payable | 64.17 | -1 | 8.89 | -2.37 | -1.09 | 6.59 | |
| Change in Unearned Revenue | - | -29.34 | -5.8 | 2.65 | 7.32 | 15.21 | |
| Change in Income Taxes | 8.01 | 8.01 | 6.51 | 3.95 | - | - | |
| Change in Other Net Operating Assets | -21.66 | -11.97 | 3 | -3.29 | 2.39 | 1.91 | |
| Operating Cash Flow | -132.94 | -176.53 | -22.43 | -28.47 | -25.23 | -54.41 | |
| Capital Expenditures | - | -0.13 | -0.51 | -0.12 | -0.04 | -0.19 | |
| Investment in Securities | -176.47 | - | - | - | - | - | |
| Investing Cash Flow | -176.29 | -0.13 | -0.51 | -0.12 | -0.04 | -0.19 | |
| Long-Term Debt Repaid | - | -0.28 | - | -2.59 | -4.44 | -2.96 | |
| Net Debt Issued (Repaid) | -0.13 | -0.28 | - | -2.59 | -4.44 | -2.96 | |
| Issuance of Common Stock | 481.95 | 337.38 | 25.98 | 2.36 | 49.04 | 40.24 | |
| Repurchase of Common Stock | - | -0.04 | - | - | - | - | |
| Other Financing Activities | - | - | - | -0.72 | - | - | |
| Financing Cash Flow | 481.83 | 337.06 | 25.98 | -0.95 | 44.6 | 37.28 | |
| Net Cash Flow | 172.6 | 160.4 | 3.05 | -29.54 | 19.32 | -17.32 | |
| Free Cash Flow | -132.94 | -176.66 | -22.94 | -28.59 | -25.27 | -54.6 | |
| Free Cash Flow Margin | - | -13855.84% | -98.51% | -121.69% | -50.98% | -452.45% | |
| Free Cash Flow Per Share | -8.00 | -27.82 | -5.25 | -8.19 | -9.64 | -26.27 | |
| Cash Interest Paid | - | - | - | 0.04 | 0.23 | 0.45 | |
| Cash Income Tax Paid | - | 0.1 | 0.8 | - | - | - | |
| Levered Free Cash Flow | -32.15 | -67.09 | -1.7 | -1.34 | -13.44 | -34.66 | |
| Unlevered Free Cash Flow | -32.15 | -67.09 | -1.7 | -1.34 | -13.31 | -34.5 | |
| Change in Working Capital | 50.35 | -13.93 | -3.92 | 0.45 | 14.44 | 12.54 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.